# Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease

> **NCT00939237** · PHASE3 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 213 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** Ateronon
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00939237
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2014-08-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00939237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00939237, "Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00939237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*